Vestmark Advisory Solutions’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,277
Closed -$222K 661
2024
Q4
$222K Sell
5,277
-668
-11% -$28.1K 0.01% 547
2024
Q3
$330K Hold
5,945
0.01% 431
2024
Q2
$244K Buy
+5,945
New +$244K 0.01% 492
2021
Q2
Sell
-2,250
Closed -$256K 798
2021
Q1
$256K Buy
+2,250
New +$256K 0.02% 644